A commonly-used HIV drug has been shown to kill off the human papilloma virus (HPV) that leads to cervical cancer in a world-first clinical trial. Researchers examined Kenyan women diagnosed with HPV positive early stage cervical cancer who were treated with the antiviral HIV drug lopinavir in Kenya. The results showed a high proportion of women diagnosed with HPV positive high-grade disease returned to normal following a short course of the new treatment.

Source: HIV drug used to reverse effects of virus that causes cervical cancer